Oligonucleotide CRDMO Service
Accelerating
Nucleic Acid Therapeutics
from Lab to Life
Accelerating
Nucleic Acid Therapeutics
We integrate synthesis, analytics, process development, and GMP manufacturing — ensuring reliability, quality, and speed.
About AXELPHEXTM
Mitsubishi Gas Chemical Company, Inc. offers a one-stop CRDMO service (AXELPHEXTM) that combines GMP-compliant oligonucleotide CDMO serivice and CRO functions for in vitro/in vivo testing to accelerate drug development.
*For information on antibody drug CDMO services, please click here.